It seems we can’t find what you’re looking for. Perhaps searching can help.
Pharmaceutical Water Systems Under FDA Scrutiny: Building Compliance-Ready Monitoring Infrastructure
Pharmaceutical Water Systems Under FDA Scrutiny: Building Compliance-Ready Monitoring Infrastructure Key Takeaways: – FDA warning letters citing water system deficiencies increased 34% between 2019-2024, with monitoring system inadequacies as primary findings – Continuous monitoring systems with electronic signatures and audit trails address 21 CFR Part 11 requirements that appear in 67% of regulatory observations –…
